NEW YORK (GenomeWeb News) – Cancer molecular diagnostics firm Epigenomics said on Thursday that it intends to launch a capital raise in January in order to fund current operations and increase its distribution capabilities.

The company intends to raise just under €5 million ($6.6 million), which would allow it to avoid having to offer a prospectus under German securities laws, it said. The planned financing would extend the cash runway of Epigenomics to at least the fourth quarter of 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.

The American Society of Human Genetics has issued a position statement on genetic testing of children.

The White House seeks to update how biotechnology products are regulated.

Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.